InnovAge Holding Corp

INNV remains in a Stage 2 recovery, consolidating around its short-term EMAs and the 50-day SMA with flattening momentum. RSI is neutral and volume has contracted, reflecting indecision. Medium-term bias stays bullish given supportive moving averages and absence of bearish patterns, while long-term uptrend remains intact. Execution should be deferred: stalk for a pullback into the confluence of the 9EMA, 20EMA, and 50DMA before initiating any long entry.

• ↑Q3 2026 revenue reached $252M, up 15.5% YoY via higher capitation and member months.
• ↑Raised FY26 revenue guidance to $950–975M and adjusted EBITDA to $85–90M, reflecting management confidence.
• ↓Q3 net loss of $29.9M highlights persistent profitability hurdles.